CID 25022354

Evogliptin

Structural Information

Molecular Formula
C19H26F3N3O3
SMILES
CC(C)(C)OC[C@@H]1C(=O)NCCN1C(=O)C[C@@H](CC2=CC(=C(C=C2F)F)F)N
InChI
InChI=1S/C19H26F3N3O3/c1-19(2,3)28-10-16-18(27)24-4-5-25(16)17(26)8-12(23)6-11-7-14(21)15(22)9-13(11)20/h7,9,12,16H,4-6,8,10,23H2,1-3H3,(H,24,27)/t12-,16-/m1/s1
InChIKey
LCDDAGSJHKEABN-MLGOLLRUSA-N
Compound name
(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-[(2-methylpropan-2-yl)oxymethyl]piperazin-2-one
Related CIDs

2D Structure

compound 2d structure
4
Annotation Hits

59
References

1777
Patents

401.19263 Da
Monoisotopic Mass

1.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 402.19991 196.6
[M+Na]+ 424.18185 201.7
[M-H]- 400.18535 194.2
[M+NH4]+ 419.22645 203.8
[M+K]+ 440.15579 196.7
[M+H-H2O]+ 384.18989 185.3
[M+HCOO]- 446.19083 205.3
[M+CH3COO]- 460.20648 225.1
[M+Na-2H]- 422.16730 191.5
[M]+ 401.19208 190.2
[M]- 401.19318 190.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe